Drugs / BRIMOCHOL™ F
last change Oct 2021 re-read 2 minutes ago

BRIMOCHOL™ F

Developed for
presbyopia
Investigated by
Visus Therapeutics

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04774237 Mar → Oct 2021 presbyopia Visus Therapeutics Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BRIMOCHOL F ClinicalTrials.gov intervention name — accepted as the source's own label NCT04774237
Route Topical “BRIMOCHOL™ F Topical Ophthalmic Solution” NCT04774237